Frequently Asked Questions
HOW DOES PRTMS WORK?
Personalized repetitive Transcranial Magnetic stimulation (PrTMS) utilizes an EEG to record nineteen functional regions of the brain in order to establish baseline brain activity. In addition to this, PrTMS uses neurocognitive tests and diagnostic surveys to assess subjective patient symptomatology. Our use of EEGs, neurocognitive surveys, and AI driven software help our physicians to deliver a custom treatment plan to our patients every week.
Similar to TMS, PrTMS stimulates nerve cells though electromagnetic pulses. While patient specific, treatment is typically recommended 5 days a week for a treatment duration recommended by the provider. Each week, a new EEG paired with your neurocognitive survey scores is used to develop an updated treatment protocol.
PrTMS is a low amplitude version of TMS with reported little to no side effects and a pain free way to bring a reduction of symptoms in patients experiencing neurocognitive disorders.
HOW MANY PATIENTS HAVE YOU TREATED?
Mindset has treated over 3,000 patients and consulted with other physicians who believed PrTMS could help their patients.
WHAT CONDITIONS DO YOU TREAT?
At MindSet, we treat the whole brain, not just the condition. In our practice, we have treated patients with depression, anxiety, PTSD, sleep disorders, ADHD, autism spectrum disorder, traumatic brain injury and concussion, and many other neurological and psychiatric conditions.
WILL PRTMS HELP ME?
Based on a retrospective analysis of PrTMS patients’ self reports, results based on neurocognitive survey scores show reductions in symptomatology for the conditions treated. These results indicate a positive use for PrTMS, however each patient is unique and results may vary. Please follow this link for a more detailed report: Publications – PeakLogic
IS PRTMS SAFE?
PrTMS is a personalized low amplitude version of conventional rTMS therapy. Because we only utilize about 20% of the power used in traditional TMS, we are able to reduce the incidence of adverse events resulting from higher power signals. It is also a non-pharmaceutical, noninvasive, and pain free way to bring reduction of symptoms for people with neurocognitive disorders. In our experience at MindSet, patients have generally not experienced safety issues from the use of PrTMS.
